@prefix dbo:	<http://dbpedia.org/ontology/> .
@prefix dbr:	<http://dbpedia.org/resource/> .
dbr:Roemheld_syndrome	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Cabotegravir	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
@prefix ns2:	<http://dbpedia.org/resource/Cabotegravir/> .
ns2:rilpivirine	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Chemotherapy-induced_peripheral_neuropathy	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
@prefix ns3:	<http://dbpedia.org/resource/Emtricitabine/rilpivirine/> .
ns3:tenofovir	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
@prefix ns4:	<http://dbpedia.org/resource/Drospirenone/ethinylestradiol/> .
ns4:levomefolic_acid	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Diazepam	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Hypomania	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Sodium_channel_blocker	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Peripheral_neuropathy	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Trileptal	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .
@prefix foaf:	<http://xmlns.com/foaf/0.1/> .
@prefix wikipedia-en:	<http://en.wikipedia.org/wiki/> .
wikipedia-en:Oxcarbazepine	foaf:primaryTopic	dbr:Oxcarbazepine .
dbr:Toll-like_receptor_4	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Desogestrel	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Frontal_lobe_epilepsy	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Absence_seizure	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Eslicarbazepine_acetate	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Musicogenic_seizure	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Drug-induced_lupus_erythematosus	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Novartis	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Benign_paroxysmal_positional_vertigo	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:List_of_psychiatric_medications	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:List_of_psychiatric_medications_by_condition_treated	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Notalgia_paresthetica	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Atypical_trigeminal_neuralgia	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
<http://dbpedia.org/resource/Stevens\u2013Johnson_syndrome>	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:CYP3A4	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Orrin_Devinsky	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Physical_dependence	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Licarbazepine	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Neuropathic_pain	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Water_intoxication	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Diabetic_neuropathy	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Drug_reaction_with_eosinophilia_and_systemic_symptoms	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Outline_of_bipolar_disorder	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
<http://dbpedia.org/resource/List_of_drugs:_Ox\u2013Oz>	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Anticonvulsant	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Carbamazepine	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:List_of_largest_pharmaceutical_settlements	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Atorvastatin	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:List_of_largest_civil_only_pharmaceutical_settlements	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Geniculate_ganglionitis	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Syndrome_of_inappropriate_antidiuretic_hormone_secretion	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Mania	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Psychiatric_medication	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:List_of_psychotropic_medications	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Thyroid_function_tests	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Thyroid_Feedback_Quantile-based_Index	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:C15H12N2O2	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Trigeminal_neuralgia	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:medication	dbr:Oxcarbazepine .
@prefix dbp:	<http://dbpedia.org/property/> .
dbr:Trigeminal_neuralgia	dbp:medication	dbr:Oxcarbazepine .
dbr:Epigenetics_of_bipolar_disorder	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
@prefix rdf:	<http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix yago:	<http://dbpedia.org/class/yago/> .
dbr:Oxcarbazepine	rdf:type	yago:WikicatAromaticCompounds ,
		yago:AromaticCompound114610088 .
@prefix owl:	<http://www.w3.org/2002/07/owl#> .
dbr:Oxcarbazepine	rdf:type	owl:Thing ,
		yago:WikicatNitrogenHeterocycles ,
		yago:Abstraction100002137 .
@prefix umbel-rc:	<http://umbel.org/umbel/rc/> .
dbr:Oxcarbazepine	rdf:type	umbel-rc:DrugProduct ,
		yago:Part113809207 ,
		dbo:Drug ,
		yago:Hydrocarbon114911057 .
@prefix wikidata:	<http://www.wikidata.org/entity/> .
dbr:Oxcarbazepine	rdf:type	wikidata:Q8386 ,
		dbo:ChemicalSubstance ,
		yago:WikicatAromaticKetones ,
		yago:WikicatKetones ,
		yago:PhysicalEntity100001930 ,
		yago:Urea115085472 ,
		yago:WikicatUreas ,
		yago:Ketone114926294 ,
		yago:Stabilizer115052667 ,
		yago:HeterocyclicCompound115025397 .
@prefix ns13:	<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#> .
dbr:Oxcarbazepine	rdf:type	ns13:ChemicalObject ,
		yago:WikicatMoodStabilizers ,
		yago:Compound114818238 ,
		yago:Chemical114806838 ,
		yago:Substance100019613 ,
		yago:Matter100020827 ,
		yago:Relation100031921 ,
		yago:OrganicCompound114727670 ,
		yago:Material114580897 .
@prefix rdfs:	<http://www.w3.org/2000/01/rdf-schema#> .
dbr:Oxcarbazepine	rdfs:label	"Oxcarbaz\u00E9pine"@fr ,
		"Okskarbazepina"@pl ,
		"\u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646"@ar ,
		"Oxcarbazepina"@it ,
		"Oxcarbazepina"@es ,
		"Oxcarbazepine"@en ,
		"Oxcarbazepina"@pt ,
		"Oxcarbazepin"@de ,
		"\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D"@uk ,
		"Oxcarbazepine"@nl ,
		"\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0438\u043D"@ru ,
		"Oxkarbazepin"@sv ,
		"\u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3"@ja ;
	rdfs:comment	"La oxcarbazepina es un f\u00E1rmaco antiepil\u00E9ptico utilizado primariamente en el tratamiento de la epilepsia. Mitiga convulsiones focales (parciales) con o sin generalizaci\u00F3n a convulsi\u00F3n t\u00F3nico-cl\u00F3nica en monoterapia de oxcarbazepina o como adyuvante de tratamiento. As\u00ED tambi\u00E9n se ha encontrado evidencia que provoca resultados favorables para la estabilizaci\u00F3n del \u00E1nimo en el trastorno bipolar. La oxcarbazepina es un derivado estructural de la carbamazepina, esta diferencia en la qu\u00EDmica ayuda a reducir el impacto sobre las funciones metab\u00F3licas del h\u00EDgado, as\u00ED como reducir ciertos efectos adversos."@es ,
		"Okskarbazepina, OXC \u2013 organiczny zwi\u0105zek chemiczny stosowany jako lek przeciwdrgawkowy i normotymiczny, zaliczany jest do prolek\u00F3w. W 1969 roku zosta\u0142 opatentowany przez J.R. Geigy Ltd. W 1999 roku dopuszczony do sprzeda\u017Cy na terenie ca\u0142ej Unii Europejskiej, w USA od 2000 roku. Stosowany doustnie u doros\u0142ych i dzieci od 6 roku \u017Cycia. Dost\u0119pny na recept\u0119 w formie tabletek lub zawiesiny."@pl ,
		"Oxcarbazepine, sold under the brand name Trileptal among others, is a medication used to treat epilepsy. For epilepsy it is used for both focal seizures and generalized seizures. It has been used both alone and as add-on therapy in people with bipolar disorder who have had no success with other treatments. It is taken by mouth. Oxcarbazepine was patented in 1969 and came into medical use in 1990. It is available as a generic medication. In 2020, it was the 144th most commonly prescribed medication in the United States, with more than 4 million prescriptions."@en ,
		"L'oxcarbaz\u00E9pine est un anti\u00E9pileptique (anticonvulsivant) ainsi qu'un thymor\u00E9gulateur ; il est principalement utilis\u00E9 dans le traitement de l'\u00E9pilepsie partielle avec ou sans g\u00E9n\u00E9ralisation secondaire. L'oxcarbaz\u00E9pine est commercialis\u00E9e sous le nom Trileptal par Novartis et disponible dans certains pays sous forme g\u00E9n\u00E9rique."@fr ,
		"\u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3\uFF08Oxcarbazepine\uFF09\u306F\u3001\u30C8\u30EA\u30EC\u30D7\u30BF\u30EB\uFF08Trileptal\uFF09\u306A\u3069\u306E\u5546\u54C1\u540D\u3067\u8CA9\u58F2\u3055\u308C\u3066\u3044\u308B\u3001\u3066\u3093\u304B\u3093\u3084\u53CC\u6975\u6027\u969C\u5BB3\u306E\u6CBB\u7642\u306B\u7528\u3044\u3089\u308C\u308B\u533B\u85AC\u54C1\u3067\u3042\u308B\u3002\u3066\u3093\u304B\u3093\u306E\u5834\u5408\u3001\u3068\u306E\u4E21\u65B9\u306B\u4F7F\u7528\u3055\u308C\u308B\u3002\u53CC\u6975\u6027\u969C\u5BB3\u306E\u5834\u5408\u3001\u4ED6\u306E\u6CBB\u7642\u6CD5\u306B\u3088\u308B\u52B9\u679C\u304C\u307F\u3089\u308C\u306A\u304B\u3063\u305F\u60A3\u8005\u3078\u306E\u5358\u72EC\u7642\u6CD5\u307E\u305F\u306F\u8FFD\u52A0\u7642\u6CD5\u306B\u7528\u3044\u3089\u308C\u308B\u3002\u6295\u4E0E\u6CD5\u306F\u7D4C\u53E3\u3067\u3042\u308B\u3002 \u4E00\u822C\u7684\u306A\u526F\u4F5C\u7528\u306B\u306F\u3001\u5410\u304D\u6C17\u3001\u5614\u5410\u3001\u3081\u307E\u3044\u3001\u7720\u6C17\u3001\u8907\u8996\u3001\u6B69\u884C\u969C\u5BB3\u306A\u3069\u304C\u3042\u3052\u3089\u308C\u308B\u3002\u91CD\u5EA6\u306E\u526F\u4F5C\u7528\u306B\u306F\u3001\u30A2\u30CA\u30D5\u30A3\u30E9\u30AD\u30B7\u30FC\u3001\u809D\u969C\u5BB3\u3001\u81B5\u708E\u3001\u81EA\u6BBA\u3001\u7570\u5E38\u306A\u5FC3\u62CD\u3001\u306A\u3069\u304C\u3042\u3052\u3089\u308C\u308B\u3002\u598A\u5A20\u4E2D\u306E\u4EBA\u3078\u306E\u6295\u4E0E\u306F\u80CE\u5150\u306B\u5BB3\u3092\u53CA\u307C\u3059\u53EF\u80FD\u6027\u304C\u3042\u308B\u304C\u3001\u526F\u4F5C\u7528\u306B\u3088\u308B\u5371\u967A\u6027\u306F\u767A\u4F5C\u306B\u3088\u308B\u5371\u967A\u6027\u3088\u308A\u4F4E\u3044\u3002\u6388\u4E73\u4E2D\u306E\u4EBA\u3078\u306E\u6295\u4E0E\u306F\u63A8\u5968\u3055\u308C\u306A\u3044\u3002\u30AB\u30EB\u30D0\u30DE\u30BC\u30D4\u30F3\u306B\u5BFE\u3057\u3066\u30A2\u30EC\u30EB\u30AE\u30FC\u304C\u3042\u308B\u4EBA\u306F\u3001\u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3\u6295\u4E0E\u306B\u3088\u308A\u751F\u3058\u308B\u5371\u967A\u6027\u306F25\uFF05\u3067\u3042\u308B\u3002\u4F5C\u7528\u6A5F\u5E8F\u306F\u660E\u78BA\u3067\u306F\u306A\u3044\u3002 \u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3\u306F1969\u5E74\u306B\u7279\u8A31\u8A8D\u53EF\u3055\u308C\u30011990\u5E74\u306B\u533B\u85AC\u54C1\u3068\u3057\u3066\u7528\u3044\u3089\u308C\u308B\u3088\u3046\u306B\u306A\u3063\u305F\u3002\u5F8C\u767A\u533B\u85AC\u54C1\u3068\u3057\u3066\u5165\u624B\u3067\u304D\u308B\u3002\u65E5\u672C\u3067\u306F\u627F\u8A8D\u3055\u308C\u3066\u3044\u306A\u3044\u30022019\u5E74\u306E\u82F1\u56FD\u306E\u56FD\u6C11\u4FDD\u5065\u30B5\u30FC\u30D3\u30B9\u306B\u639B\u304B\u308B1\u304B\u6708\u5206\u306E\u8CBB\u7528\u306F\u3001\u7D046.50\u30DD\u30F3\u30C9\u3067\u3042\u308B\u3002\u7C73\u56FD\u3067\u306E1\u304B\u6708\u5206\u306E\u5378\u58F2\u4FA1\u683C\u306F\u7D047.15\u7C73\u30C9\u30EB\u3067\u3042\u308B\u3002"@ja ,
		"\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D (\u0430\u043D\u0433\u043B. Oxcarbazepine, \u043B\u0430\u0442. Oxcarbazepinum) \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u044F\u043A\u0438\u0439 \u0437\u0430 \u0441\u0432\u043E\u0454\u044E \u0445\u0456\u043C\u0456\u0447\u043D\u043E\u044E \u0441\u0442\u0440\u0443\u043A\u0442\u0443\u0440\u043E\u044E \u0454 \u0430\u043D\u0430\u043B\u043E\u0433\u043E\u043C \u0456\u043D\u0448\u043E\u0433\u043E \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0443 \u2014 \u043A\u0430\u0440\u0431\u0430\u043C\u0430\u0437\u0435\u043F\u0456\u043D\u0443, \u0449\u043E \u0454 \u043F\u043E\u0445\u0456\u0434\u043D\u0438\u043C \u0442\u0440\u0438\u0446\u0438\u043A\u043B\u0456\u0447\u043D\u043E\u0433\u043E , \u0442\u0430 \u043D\u0430\u043B\u0435\u0436\u0438\u0442\u044C \u0434\u043E \u043F\u0440\u043E\u0442\u0438\u0441\u0443\u0434\u043E\u043C\u043D\u0438\u0445 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432. \u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0432\u0438\u043A\u043B\u044E\u0447\u043D\u043E \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E. \u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D \u0443\u043F\u0435\u0440\u0448\u0435 \u0441\u0438\u043D\u0442\u0435\u0437\u043E\u0432\u0430\u043D\u0438\u0439 \u0443 1966 \u0440\u043E\u0446\u0456, \u0442\u0430 \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0443 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0456\u0439 \u043F\u0440\u0430\u043A\u0442\u0438\u0446\u0456 \u0437 1990 \u0440\u043E\u043A\u0443."@uk ,
		"\u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Oxcarbazepine) \u0647\u0648 \u062F\u0648\u0627\u0621 \u0645\u0636\u0627\u062F \u0644\u0644\u0627\u062E\u062A\u0644\u0627\u062C \u064A\u0633\u062A\u0639\u0645\u0644 \u0641\u064A \u0627\u0644\u0645\u0642\u0627\u0645 \u0627\u0644\u0623\u0648\u0644 \u0644\u0639\u0644\u0627\u062C \u0627\u0644\u0635\u0631\u0639. \u0647\u0646\u0627\u0643 \u0628\u0639\u0636 \u0627\u0644\u0623\u062F\u0644\u0629 \u0639\u0644\u0649 \u0623\u0646 \u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646 \u0643\u0639\u0627\u0645\u0644 \u0627\u0633\u062A\u0642\u0631\u0627\u0631 \u0627\u0644\u0645\u0632\u0627\u062C\u060C \u0648\u0628\u0627\u0644\u062A\u0627\u0644\u064A\u060C \u064A\u0645\u0643\u0646 \u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0643\u0639\u0644\u0627\u062C \u0625\u0636\u0627\u0641\u064A \u0644\u0644\u0627\u0636\u0637\u0631\u0627\u0628 \u062B\u0646\u0627\u0626\u064A \u0627\u0644\u0642\u0637\u0628 \u0641\u064A \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0644\u0630\u064A\u0646 \u0641\u0634\u0644 \u0645\u0639\u0647\u0645 \u0627\u0644\u062F\u0648\u0627\u0621 \u0627\u0644\u0645\u0635\u0631\u062D \u0628\u0647\u0650 \u0623\u0648 \u063A\u064A\u0631 \u0627\u0644\u0642\u0627\u062F\u0631\u064A\u0646 \u0639\u0644\u0649 \u062A\u062D\u0645\u0644 \u0627\u0644\u0639\u0644\u0627\u062C\u0627\u062A \u0627\u0644\u0645\u0639\u062A\u0645\u062F\u0629. \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u062A\u0634\u0645\u0644 \u0627\u0644\u063A\u062B\u064A\u0627\u0646\u060C \u0627\u0644\u062A\u0642\u064A\u0624\u060C \u0627\u0644\u062F\u0648\u062E\u0629\u060C \u0627\u0644\u0646\u0639\u0627\u0633\u060C \u0627\u0644\u0635\u062F\u0627\u0639\u060C \u0627\u0644\u0631\u0624\u064A\u0629 \u0627\u0644\u0645\u0632\u062F\u0648\u062C\u0629 \u0648\u0635\u0639\u0648\u0628\u0627\u062A \u0645\u0639 \u0627\u0644\u0645\u0634\u064A. \u0642\u062F \u062A\u062D\u062F\u062B \u0635\u062F\u0645\u0629 \u0627\u0644\u062D\u0633\u0627\u0633\u064A\u0629 \u0645\u0646 \u0627\u0644\u0639\u0642\u0627\u0631\u060C \u0639\u0644\u0649 \u0627\u0644\u0631\u063A\u0645 \u0645\u0646 \u0623\u0646\u0647\u0627 \u063A\u064A\u0631 \u0634\u0627\u0626\u0639\u0629 \u0627\u0644\u062D\u062F\u0648\u062B. \u0646\u062A\u064A\u062C\u0629 \u0644\u0644\u062A\u0634\u0627\u0628\u0647 \u0627\u0644\u0647\u064A\u0643\u0644\u064A \u0628\u064A\u0646 \u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646 \u0648\u0627\u0644\u0643\u0627\u0631\u0628\u0627\u0645\u0627\u0632\u064A\u0628\u064A\u0646 \u0647\u0646\u0627\u0643 \u0641\u0631\u0635\u0629 \u062D\u0648\u0627\u0644\u064A 25-30\u066A \u0645\u0646 \u0627\u0644\u062A\u0641\u0627\u0639\u0644 \u0628\u064A\u0646 \u0627\u0644\u062F\u0648\u0627\u0626\u064A\u0646."@ar ,
		"Oxcarbazepine is een geneesmiddel voor de behandeling van epilepsie. Het is een derivaat van carbamazepine, met een keton in plaats van een dubbele koolstof-koolstofbinding op positie \"10\" in de dibenzoazepinestructuur. Het is een prodrug, hetgeen betekent dat het zelf geen farmaceutisch actieve stof is; maar nadat het is ingenomen, wordt het snel en bijna volledig omgezet in de actieve metaboliet 10-hydroxycarbamazepine (licarbazepine), waarvan de (S)-enantiomeer, ((S)-licarbazepine), de eigenlijke actieve stof is."@nl ,
		"Oxcarbazepina, vendida sob o nome comercial Trileptal, entre outros, \u00E9 um medicamento usado no tratamento da epilepsia e do transtorno bipolar. Para epilepsia, \u00E9 usado em pessoas que apresentam crises focais e/ou . Em pessoas com transtorno bipolar que n\u00E3o respondem bem a outros tratamentos, a oxcarbazepina pode ser utilizada como terapia adjuvante. \u00C9 tomado por via oral. A oxcarbazepina foi patenteada em 1969 e introduzida no mercado em 1990. Est\u00E1 dispon\u00EDvel como um medicamento gen\u00E9rico . Em 2018, era o 158\u00BA medicamento mais prescrito nos Estados Unidos, com mais de 3 milh\u00F5es de prescri\u00E7\u00F5es."@pt ,
		"L'oxcarbazepina o oxcarbamazepina \u00E8 un farmaco chimicamente correlato alla carbamazepina dalla quale deriva; differisce clinicamente da questa per il minor impegno metabolico a livello epatico e per la riduzione dei, se pur rari, fenomeni di grave anemia. Pur con minori effetti collaterali della carbamazepina, l'oxcarbazepina mostra la stessa efficacia, lo stesso meccanismo d'azione sul canale Voltaggio dipendente del Na+ ed \u00E8, inoltre, generalmente usata per il trattamento delle stesse condizioni patologiche."@it ,
		"Oxcarbazepin z\u00E4hlt chemisch zur Klasse der Dibenzazepine und ist ein Abk\u00F6mmling des Carbamazepins. Es ist ein Arzneistoff, der zur Dauerbehandlung bestimmter Formen der Epilepsie als Antikonvulsivum verwendet wird."@de ,
		"Oxkarbazepin \u00E4r en kemisk f\u00F6rening med formeln C15H12N2O2. \u00C4mnet \u00E4r ett antiepileptikum, det vill s\u00E4ga ett l\u00E4kemedel mot epileptiska anfall. \u00C4mnet marknadsf\u00F6rs under bland annat Trileptal. Oxkarbazepin kan anv\u00E4ndas antingen som ett sj\u00E4lvst\u00E4ndigt l\u00E4kemedel eller i kombination med andra preparat f\u00F6r att motverka anfall. Det verkar genom att minska onormal elektrisk aktivitet i hj\u00E4rnan. Oxkarbazepin kan ibland \u00E4ven anv\u00E4nds f\u00F6r att behandla bipol\u00E4r sjukdom."@sv ,
		"\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0438\u0301\u043D (\u0442\u043E\u0440\u0433\u043E\u0432\u044B\u0435 \u043D\u0430\u0438\u043C\u0435\u043D\u043E\u0432\u0430\u043D\u0438\u044F \u00ABTrileptal\u00BB (Novartis), \u00ABApydan\u00BB (Desitin), \u00ABOxcarbazepine\u00BB (Teva)) \u2014 \u043F\u0440\u043E\u0442\u0438\u0432\u043E\u044D\u043F\u0438\u043B\u0435\u043F\u0442\u0438\u0447\u0435\u0441\u043A\u043E\u0435 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432\u0435\u043D\u043D\u043E\u0435 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u043E \u0438\u0437 \u0433\u0440\u0443\u043F\u043F\u044B \u043F\u0440\u043E\u0438\u0437\u0432\u043E\u0434\u043D\u044B\u0445 . \u0418\u0441\u043F\u043E\u043B\u044C\u0437\u0443\u0435\u0442\u0441\u044F \u0432 \u043A\u0430\u0447\u0435\u0441\u0442\u0432\u0435 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0430 \u043F\u0435\u0440\u0432\u043E\u0433\u043E \u0432\u044B\u0431\u043E\u0440\u0430 \u043A\u0430\u043A \u0432 \u0441\u043E\u0441\u0442\u0430\u0432\u0435 \u043C\u043E\u043D\u043E\u0442\u0435\u0440\u0430\u043F\u0438\u0438, \u0442\u0430\u043A \u0438 \u043A\u043E\u043C\u0431\u0438\u043D\u0438\u0440\u043E\u0432\u0430\u043D\u043D\u043E\u0439 \u0442\u0435\u0440\u0430\u043F\u0438\u0438 \u043F\u0430\u0440\u0446\u0438\u0430\u043B\u044C\u043D\u044B\u0445 \u044D\u043F\u0438\u043B\u0435\u043F\u0442\u0438\u0447\u0435\u0441\u043A\u0438\u0445 \u043F\u0440\u0438\u0441\u0442\u0443\u043F\u043E\u0432 \u0443 \u0434\u0435\u0442\u0435\u0439 \u0438 \u0432\u0437\u0440\u043E\u0441\u043B\u044B\u0445. \u0412\u043F\u0435\u0440\u0432\u044B\u0435 \u0441\u0438\u043D\u0442\u0435\u0437\u0438\u0440\u043E\u0432\u0430\u043D \u0432 1966 \u0433\u043E\u0434\u0443, \u043E\u0434\u043E\u0431\u0440\u0435\u043D \u043A \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044E \u0432 \u043A\u0430\u0447\u0435\u0441\u0442\u0432\u0435 \u0430\u043D\u0442\u0438\u043A\u043E\u043D\u0432\u0443\u043B\u044C\u0441\u0430\u043D\u0442\u0430 \u0432 \u0414\u0430\u043D\u0438\u0438 \u0432 1990 \u0433\u043E\u0434\u0443. \u041A 1999 \u0433\u043E\u0434\u0443 \u043F\u0440\u0438\u043C\u0435\u043D\u044F\u043B\u0441\u044F \u0432\u043E \u0432\u0441\u0435\u0445 \u0441\u0442\u0440\u0430\u043D\u0430\u0445 \u0415\u0432\u0440\u043E\u0441\u043E\u044E\u0437\u0430. \u0412 \u0421\u0428\u0410 \u043E\u0434\u043E\u0431\u0440\u0435\u043D \u043A \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044E \u0432 2000 \u0433\u043E\u0434\u0443."@ru ;
	foaf:depiction	<http://commons.wikimedia.org/wiki/Special:FilePath/Oxcarbazepine_3d_structure.png> ,
		<http://commons.wikimedia.org/wiki/Special:FilePath/Oxcarbazepine.svg> ,
		<http://commons.wikimedia.org/wiki/Special:FilePath/Trileptal_tablets.jpg> ,
		<http://commons.wikimedia.org/wiki/Special:FilePath/Trileptal_Oral_Suspension_100mg_per_ml.jpg> .
@prefix dct:	<http://purl.org/dc/terms/> .
@prefix dbc:	<http://dbpedia.org/resource/Category:> .
dbr:Oxcarbazepine	dct:subject	dbc:Prodrugs ,
		dbc:Novartis_brands ,
		dbc:Dibenzazepines ,
		dbc:Teratogens ,
		dbc:Mood_stabilizers ,
		dbc:Wikipedia_medicine_articles_ready_to_translate ,
		dbc:Embryotoxicants ,
		dbc:Ketones ,
		dbc:Anticonvulsants ,
		dbc:Ureas ;
	dbo:abstract	"Oxcarbazepine, sold under the brand name Trileptal among others, is a medication used to treat epilepsy. For epilepsy it is used for both focal seizures and generalized seizures. It has been used both alone and as add-on therapy in people with bipolar disorder who have had no success with other treatments. It is taken by mouth. Common side effects include nausea, vomiting, dizziness, drowsiness, double vision and trouble with walking. Serious side effects may include anaphylaxis, liver problems, pancreatitis, suicide ideation, and an abnormal heart beat. While use during pregnancy may harm the baby, use may be less risky than having a seizure. Use is not recommended during breastfeeding. In those with an allergy to carbamazepine there is a 25% risk of problems with oxcarbazepine. How it works is not entirely clear. Oxcarbazepine was patented in 1969 and came into medical use in 1990. It is available as a generic medication. In 2020, it was the 144th most commonly prescribed medication in the United States, with more than 4 million prescriptions."@en ,
		"\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0438\u0301\u043D (\u0442\u043E\u0440\u0433\u043E\u0432\u044B\u0435 \u043D\u0430\u0438\u043C\u0435\u043D\u043E\u0432\u0430\u043D\u0438\u044F \u00ABTrileptal\u00BB (Novartis), \u00ABApydan\u00BB (Desitin), \u00ABOxcarbazepine\u00BB (Teva)) \u2014 \u043F\u0440\u043E\u0442\u0438\u0432\u043E\u044D\u043F\u0438\u043B\u0435\u043F\u0442\u0438\u0447\u0435\u0441\u043A\u043E\u0435 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432\u0435\u043D\u043D\u043E\u0435 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u043E \u0438\u0437 \u0433\u0440\u0443\u043F\u043F\u044B \u043F\u0440\u043E\u0438\u0437\u0432\u043E\u0434\u043D\u044B\u0445 . \u0418\u0441\u043F\u043E\u043B\u044C\u0437\u0443\u0435\u0442\u0441\u044F \u0432 \u043A\u0430\u0447\u0435\u0441\u0442\u0432\u0435 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0430 \u043F\u0435\u0440\u0432\u043E\u0433\u043E \u0432\u044B\u0431\u043E\u0440\u0430 \u043A\u0430\u043A \u0432 \u0441\u043E\u0441\u0442\u0430\u0432\u0435 \u043C\u043E\u043D\u043E\u0442\u0435\u0440\u0430\u043F\u0438\u0438, \u0442\u0430\u043A \u0438 \u043A\u043E\u043C\u0431\u0438\u043D\u0438\u0440\u043E\u0432\u0430\u043D\u043D\u043E\u0439 \u0442\u0435\u0440\u0430\u043F\u0438\u0438 \u043F\u0430\u0440\u0446\u0438\u0430\u043B\u044C\u043D\u044B\u0445 \u044D\u043F\u0438\u043B\u0435\u043F\u0442\u0438\u0447\u0435\u0441\u043A\u0438\u0445 \u043F\u0440\u0438\u0441\u0442\u0443\u043F\u043E\u0432 \u0443 \u0434\u0435\u0442\u0435\u0439 \u0438 \u0432\u0437\u0440\u043E\u0441\u043B\u044B\u0445. \u041E\u0442 \u043A\u0430\u0440\u0431\u0430\u043C\u0430\u0437\u0435\u043F\u0438\u043D\u0430 \u0441\u0442\u0440\u0443\u043A\u0442\u0443\u0440\u043D\u043E \u043E\u0442\u043B\u0438\u0447\u0430\u0435\u0442\u0441\u044F \u043D\u0430\u043B\u0438\u0447\u0438\u0435\u043C \u0434\u043E\u043F\u043E\u043B\u043D\u0438\u0442\u0435\u043B\u044C\u043D\u043E\u0433\u043E \u0430\u0442\u043E\u043C\u0430 \u043A\u0438\u0441\u043B\u043E\u0440\u043E\u0434\u0430 \u0443 \u0431\u0435\u043D\u0437\u0438\u043B\u043A\u0430\u0440\u0431\u043E\u043A\u0441\u0430\u043C\u0438\u0434\u043D\u043E\u0439 \u0433\u0440\u0443\u043F\u043F\u044B. \u0414\u0430\u043D\u043D\u043E\u0435 \u043E\u0442\u043B\u0438\u0447\u0438\u0435 \u0443\u043C\u0435\u043D\u044C\u0448\u0430\u0435\u0442 \u0432\u043E\u0437\u0434\u0435\u0439\u0441\u0442\u0432\u0438\u0435 \u043C\u0435\u0442\u0430\u0431\u043E\u043B\u0438\u0442\u043E\u0432 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0430 \u043D\u0430 \u043F\u0435\u0447\u0435\u043D\u044C, \u0430 \u0442\u0430\u043A\u0436\u0435 \u043F\u0440\u0435\u0434\u043E\u0442\u0432\u0440\u0430\u0449\u0430\u0435\u0442 \u0442\u044F\u0436\u0451\u043B\u044B\u0435 \u0444\u043E\u0440\u043C\u044B \u0430\u043D\u0435\u043C\u0438\u0438, \u0438\u043D\u043E\u0433\u0434\u0430 \u0441\u0432\u044F\u0437\u0430\u043D\u043D\u044B\u0435 \u0441 \u043F\u0440\u0438\u0451\u043C\u043E\u043C \u043A\u0430\u0440\u0431\u0430\u043C\u0430\u0437\u0435\u043F\u0438\u043D\u0430. \u041D\u0435 \u0441\u0447\u0438\u0442\u0430\u044F \u0443\u043C\u0435\u043D\u044C\u0448\u0435\u043D\u0438\u044F \u043A\u043E\u043B\u0438\u0447\u0435\u0441\u0442\u0432\u0430 \u043F\u043E\u0431\u043E\u0447\u043D\u044B\u0445 \u044D\u0444\u0444\u0435\u043A\u0442\u043E\u0432, \u0432 \u043E\u0441\u0442\u0430\u043B\u044C\u043D\u043E\u043C \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442 \u0444\u0430\u0440\u043C\u0430\u043A\u043E\u043B\u043E\u0433\u0438\u0447\u0435\u0441\u043A\u0438 \u0430\u043D\u0430\u043B\u043E\u0433\u0438\u0447\u0435\u043D \u043A\u0430\u0440\u0431\u0430\u043C\u0430\u0437\u0435\u043F\u0438\u043D\u0443, \u043F\u0440\u0435\u0434\u043F\u043E\u043B\u043E\u0436\u0438\u0442\u0435\u043B\u044C\u043D\u043E \u0438\u043C\u0435\u0435\u0442 \u0442\u043E\u0442 \u0436\u0435 \u043C\u0435\u0445\u0430\u043D\u0438\u0437\u043C \u0434\u0435\u0439\u0441\u0442\u0432\u0438\u044F, \u0441\u0432\u044F\u0437\u0430\u043D\u043D\u044B\u0439 \u0441 \u0431\u043B\u043E\u043A\u0438\u0440\u043E\u0432\u0430\u043D\u0438\u0435\u043C \u043D\u0430\u0442\u0440\u0438\u0435\u0432\u044B\u0445 \u043A\u0430\u043D\u0430\u043B\u043E\u0432, \u0447\u0442\u043E \u043F\u0440\u0438\u0432\u043E\u0434\u0438\u0442 \u043A \u0441\u0442\u0430\u0431\u0438\u043B\u0438\u0437\u0430\u0446\u0438\u0438 \u043C\u0435\u043C\u0431\u0440\u0430\u043D \u043F\u0435\u0440\u0435\u0432\u043E\u0437\u0431\u0443\u0436\u0434\u0435\u043D\u043D\u044B\u0445 \u043D\u0435\u0439\u0440\u043E\u043D\u043E\u0432, \u0438\u043D\u0433\u0438\u0431\u0438\u0440\u043E\u0432\u0430\u043D\u0438\u044E \u0432\u043E\u0437\u043D\u0438\u043A\u043D\u043E\u0432\u0435\u043D\u0438\u044F \u0441\u0435\u0440\u0438\u0439\u043D\u044B\u0445 \u0440\u0430\u0437\u0440\u044F\u0434\u043E\u0432 \u043D\u0435\u0439\u0440\u043E\u043D\u043E\u0432 \u0438 \u0441\u043D\u0438\u0436\u0435\u043D\u0438\u044E \u0441\u0438\u043D\u0430\u043F\u0442\u0438\u0447\u0435\u0441\u043A\u043E\u0433\u043E \u043F\u0440\u043E\u0432\u0435\u0434\u0435\u043D\u0438\u044F \u0438\u043C\u043F\u0443\u043B\u044C\u0441\u043E\u0432. \u0412\u043F\u0435\u0440\u0432\u044B\u0435 \u0441\u0438\u043D\u0442\u0435\u0437\u0438\u0440\u043E\u0432\u0430\u043D \u0432 1966 \u0433\u043E\u0434\u0443, \u043E\u0434\u043E\u0431\u0440\u0435\u043D \u043A \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044E \u0432 \u043A\u0430\u0447\u0435\u0441\u0442\u0432\u0435 \u0430\u043D\u0442\u0438\u043A\u043E\u043D\u0432\u0443\u043B\u044C\u0441\u0430\u043D\u0442\u0430 \u0432 \u0414\u0430\u043D\u0438\u0438 \u0432 1990 \u0433\u043E\u0434\u0443. \u041A 1999 \u0433\u043E\u0434\u0443 \u043F\u0440\u0438\u043C\u0435\u043D\u044F\u043B\u0441\u044F \u0432\u043E \u0432\u0441\u0435\u0445 \u0441\u0442\u0440\u0430\u043D\u0430\u0445 \u0415\u0432\u0440\u043E\u0441\u043E\u044E\u0437\u0430. \u0412 \u0421\u0428\u0410 \u043E\u0434\u043E\u0431\u0440\u0435\u043D \u043A \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044E \u0432 2000 \u0433\u043E\u0434\u0443. \u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0438\u043D \u0432\u0445\u043E\u0434\u0438\u0442 \u0432 \u043F\u0435\u0440\u0435\u0447\u0435\u043D\u044C \u0436\u0438\u0437\u043D\u0435\u043D\u043D\u043E \u043D\u0435\u043E\u0431\u0445\u043E\u0434\u0438\u043C\u044B\u0445 \u0438 \u0432\u0430\u0436\u043D\u0435\u0439\u0448\u0438\u0445 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432\u0435\u043D\u043D\u044B\u0445 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u043E\u0432."@ru ,
		"Oxcarbazepin z\u00E4hlt chemisch zur Klasse der Dibenzazepine und ist ein Abk\u00F6mmling des Carbamazepins. Es ist ein Arzneistoff, der zur Dauerbehandlung bestimmter Formen der Epilepsie als Antikonvulsivum verwendet wird."@de ,
		"\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D (\u0430\u043D\u0433\u043B. Oxcarbazepine, \u043B\u0430\u0442. Oxcarbazepinum) \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u044F\u043A\u0438\u0439 \u0437\u0430 \u0441\u0432\u043E\u0454\u044E \u0445\u0456\u043C\u0456\u0447\u043D\u043E\u044E \u0441\u0442\u0440\u0443\u043A\u0442\u0443\u0440\u043E\u044E \u0454 \u0430\u043D\u0430\u043B\u043E\u0433\u043E\u043C \u0456\u043D\u0448\u043E\u0433\u043E \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0443 \u2014 \u043A\u0430\u0440\u0431\u0430\u043C\u0430\u0437\u0435\u043F\u0456\u043D\u0443, \u0449\u043E \u0454 \u043F\u043E\u0445\u0456\u0434\u043D\u0438\u043C \u0442\u0440\u0438\u0446\u0438\u043A\u043B\u0456\u0447\u043D\u043E\u0433\u043E , \u0442\u0430 \u043D\u0430\u043B\u0435\u0436\u0438\u0442\u044C \u0434\u043E \u043F\u0440\u043E\u0442\u0438\u0441\u0443\u0434\u043E\u043C\u043D\u0438\u0445 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432. \u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0432\u0438\u043A\u043B\u044E\u0447\u043D\u043E \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E. \u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D \u0443\u043F\u0435\u0440\u0448\u0435 \u0441\u0438\u043D\u0442\u0435\u0437\u043E\u0432\u0430\u043D\u0438\u0439 \u0443 1966 \u0440\u043E\u0446\u0456, \u0442\u0430 \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0443 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0456\u0439 \u043F\u0440\u0430\u043A\u0442\u0438\u0446\u0456 \u0437 1990 \u0440\u043E\u043A\u0443."@uk ,
		"Oxcarbazepina, vendida sob o nome comercial Trileptal, entre outros, \u00E9 um medicamento usado no tratamento da epilepsia e do transtorno bipolar. Para epilepsia, \u00E9 usado em pessoas que apresentam crises focais e/ou . Em pessoas com transtorno bipolar que n\u00E3o respondem bem a outros tratamentos, a oxcarbazepina pode ser utilizada como terapia adjuvante. \u00C9 tomado por via oral. Os efeitos colaterais mais comuns s\u00E3o n\u00E1usea, v\u00F4mito, tontura, sonol\u00EAncia, vis\u00E3o dupla e ataxia. Os efeitos colaterais graves podem incluir anafilaxia, danos hep\u00E1ticos, pancreatite, idea\u00E7\u00E3o suicida e arritmia card\u00EDaca. Embora o uso durante a gravidez possa prejudicar o feto, a administra\u00E7\u00E3o do f\u00E1rmaco geralmente \u00E9 mais seguro do que o risco de ocorrer uma convuls\u00E3o. Seu uso n\u00E3o \u00E9 recomendado durante a amamenta\u00E7\u00E3o. Em pessoas al\u00E9rgicas \u00E0 carbamazepina, h\u00E1 uma probabilidade de 25% de que tamb\u00E9m sejam al\u00E9rgicas \u00E0 oxcarbazepina. Seu mecanismo de a\u00E7\u00E3o n\u00E3o \u00E9 totalmente conhecido. A oxcarbazepina foi patenteada em 1969 e introduzida no mercado em 1990. Est\u00E1 dispon\u00EDvel como um medicamento gen\u00E9rico . Em 2018, era o 158\u00BA medicamento mais prescrito nos Estados Unidos, com mais de 3 milh\u00F5es de prescri\u00E7\u00F5es."@pt ,
		"Oxcarbazepine is een geneesmiddel voor de behandeling van epilepsie. Het is een derivaat van carbamazepine, met een keton in plaats van een dubbele koolstof-koolstofbinding op positie \"10\" in de dibenzoazepinestructuur. Het is een prodrug, hetgeen betekent dat het zelf geen farmaceutisch actieve stof is; maar nadat het is ingenomen, wordt het snel en bijna volledig omgezet in de actieve metaboliet 10-hydroxycarbamazepine (licarbazepine), waarvan de (S)-enantiomeer, ((S)-licarbazepine), de eigenlijke actieve stof is. Oxcarbazepine is sinds 1991 internationaal op de markt. Het wordt verkocht door Novartis onder de merknaam Trileptal en is ook als generiek geneesmiddel verkrijgbaar (het middel is niet meer beschermd door een octrooi). Oxcarbazepine wordt voorgeschreven voor de behandeling van parti\u00EBle epilepsie met of zonder secundaire veralgemening, bij volwassenen of kinderen vanaf 6 jaar. Het kan worden voorgeschreven in de plaats van carbamazepine wanneer dit laatste middel onvoldoende werkt of onaangename bijwerkingen heeft. De belangrijkste bijwerkingen van oxcarbazepine zijn: misselijkheid, slaperigheid, dubbelzien en te weinig natrium in het bloed (hetgeen zich onder meer uit in plotse hevige vermoeidheid, sufheid, verminderde eetlust, braken en diarree). Er is in 2009 een andere prodrug van eslicarbazepine op de markt verschenen, namelijk"@nl ,
		"\u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3\uFF08Oxcarbazepine\uFF09\u306F\u3001\u30C8\u30EA\u30EC\u30D7\u30BF\u30EB\uFF08Trileptal\uFF09\u306A\u3069\u306E\u5546\u54C1\u540D\u3067\u8CA9\u58F2\u3055\u308C\u3066\u3044\u308B\u3001\u3066\u3093\u304B\u3093\u3084\u53CC\u6975\u6027\u969C\u5BB3\u306E\u6CBB\u7642\u306B\u7528\u3044\u3089\u308C\u308B\u533B\u85AC\u54C1\u3067\u3042\u308B\u3002\u3066\u3093\u304B\u3093\u306E\u5834\u5408\u3001\u3068\u306E\u4E21\u65B9\u306B\u4F7F\u7528\u3055\u308C\u308B\u3002\u53CC\u6975\u6027\u969C\u5BB3\u306E\u5834\u5408\u3001\u4ED6\u306E\u6CBB\u7642\u6CD5\u306B\u3088\u308B\u52B9\u679C\u304C\u307F\u3089\u308C\u306A\u304B\u3063\u305F\u60A3\u8005\u3078\u306E\u5358\u72EC\u7642\u6CD5\u307E\u305F\u306F\u8FFD\u52A0\u7642\u6CD5\u306B\u7528\u3044\u3089\u308C\u308B\u3002\u6295\u4E0E\u6CD5\u306F\u7D4C\u53E3\u3067\u3042\u308B\u3002 \u4E00\u822C\u7684\u306A\u526F\u4F5C\u7528\u306B\u306F\u3001\u5410\u304D\u6C17\u3001\u5614\u5410\u3001\u3081\u307E\u3044\u3001\u7720\u6C17\u3001\u8907\u8996\u3001\u6B69\u884C\u969C\u5BB3\u306A\u3069\u304C\u3042\u3052\u3089\u308C\u308B\u3002\u91CD\u5EA6\u306E\u526F\u4F5C\u7528\u306B\u306F\u3001\u30A2\u30CA\u30D5\u30A3\u30E9\u30AD\u30B7\u30FC\u3001\u809D\u969C\u5BB3\u3001\u81B5\u708E\u3001\u81EA\u6BBA\u3001\u7570\u5E38\u306A\u5FC3\u62CD\u3001\u306A\u3069\u304C\u3042\u3052\u3089\u308C\u308B\u3002\u598A\u5A20\u4E2D\u306E\u4EBA\u3078\u306E\u6295\u4E0E\u306F\u80CE\u5150\u306B\u5BB3\u3092\u53CA\u307C\u3059\u53EF\u80FD\u6027\u304C\u3042\u308B\u304C\u3001\u526F\u4F5C\u7528\u306B\u3088\u308B\u5371\u967A\u6027\u306F\u767A\u4F5C\u306B\u3088\u308B\u5371\u967A\u6027\u3088\u308A\u4F4E\u3044\u3002\u6388\u4E73\u4E2D\u306E\u4EBA\u3078\u306E\u6295\u4E0E\u306F\u63A8\u5968\u3055\u308C\u306A\u3044\u3002\u30AB\u30EB\u30D0\u30DE\u30BC\u30D4\u30F3\u306B\u5BFE\u3057\u3066\u30A2\u30EC\u30EB\u30AE\u30FC\u304C\u3042\u308B\u4EBA\u306F\u3001\u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3\u6295\u4E0E\u306B\u3088\u308A\u751F\u3058\u308B\u5371\u967A\u6027\u306F25\uFF05\u3067\u3042\u308B\u3002\u4F5C\u7528\u6A5F\u5E8F\u306F\u660E\u78BA\u3067\u306F\u306A\u3044\u3002 \u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3\u306F1969\u5E74\u306B\u7279\u8A31\u8A8D\u53EF\u3055\u308C\u30011990\u5E74\u306B\u533B\u85AC\u54C1\u3068\u3057\u3066\u7528\u3044\u3089\u308C\u308B\u3088\u3046\u306B\u306A\u3063\u305F\u3002\u5F8C\u767A\u533B\u85AC\u54C1\u3068\u3057\u3066\u5165\u624B\u3067\u304D\u308B\u3002\u65E5\u672C\u3067\u306F\u627F\u8A8D\u3055\u308C\u3066\u3044\u306A\u3044\u30022019\u5E74\u306E\u82F1\u56FD\u306E\u56FD\u6C11\u4FDD\u5065\u30B5\u30FC\u30D3\u30B9\u306B\u639B\u304B\u308B1\u304B\u6708\u5206\u306E\u8CBB\u7528\u306F\u3001\u7D046.50\u30DD\u30F3\u30C9\u3067\u3042\u308B\u3002\u7C73\u56FD\u3067\u306E1\u304B\u6708\u5206\u306E\u5378\u58F2\u4FA1\u683C\u306F\u7D047.15\u7C73\u30C9\u30EB\u3067\u3042\u308B\u3002"@ja ,
		"Oxkarbazepin \u00E4r en kemisk f\u00F6rening med formeln C15H12N2O2. \u00C4mnet \u00E4r ett antiepileptikum, det vill s\u00E4ga ett l\u00E4kemedel mot epileptiska anfall. \u00C4mnet marknadsf\u00F6rs under bland annat Trileptal. Oxkarbazepin kan anv\u00E4ndas antingen som ett sj\u00E4lvst\u00E4ndigt l\u00E4kemedel eller i kombination med andra preparat f\u00F6r att motverka anfall. Det verkar genom att minska onormal elektrisk aktivitet i hj\u00E4rnan. Oxkarbazepin kan ibland \u00E4ven anv\u00E4nds f\u00F6r att behandla bipol\u00E4r sjukdom."@sv ,
		"\u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Oxcarbazepine) \u0647\u0648 \u062F\u0648\u0627\u0621 \u0645\u0636\u0627\u062F \u0644\u0644\u0627\u062E\u062A\u0644\u0627\u062C \u064A\u0633\u062A\u0639\u0645\u0644 \u0641\u064A \u0627\u0644\u0645\u0642\u0627\u0645 \u0627\u0644\u0623\u0648\u0644 \u0644\u0639\u0644\u0627\u062C \u0627\u0644\u0635\u0631\u0639. \u0647\u0646\u0627\u0643 \u0628\u0639\u0636 \u0627\u0644\u0623\u062F\u0644\u0629 \u0639\u0644\u0649 \u0623\u0646 \u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646 \u0643\u0639\u0627\u0645\u0644 \u0627\u0633\u062A\u0642\u0631\u0627\u0631 \u0627\u0644\u0645\u0632\u0627\u062C\u060C \u0648\u0628\u0627\u0644\u062A\u0627\u0644\u064A\u060C \u064A\u0645\u0643\u0646 \u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0643\u0639\u0644\u0627\u062C \u0625\u0636\u0627\u0641\u064A \u0644\u0644\u0627\u0636\u0637\u0631\u0627\u0628 \u062B\u0646\u0627\u0626\u064A \u0627\u0644\u0642\u0637\u0628 \u0641\u064A \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0644\u0630\u064A\u0646 \u0641\u0634\u0644 \u0645\u0639\u0647\u0645 \u0627\u0644\u062F\u0648\u0627\u0621 \u0627\u0644\u0645\u0635\u0631\u062D \u0628\u0647\u0650 \u0623\u0648 \u063A\u064A\u0631 \u0627\u0644\u0642\u0627\u062F\u0631\u064A\u0646 \u0639\u0644\u0649 \u062A\u062D\u0645\u0644 \u0627\u0644\u0639\u0644\u0627\u062C\u0627\u062A \u0627\u0644\u0645\u0639\u062A\u0645\u062F\u0629. \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u062A\u0634\u0645\u0644 \u0627\u0644\u063A\u062B\u064A\u0627\u0646\u060C \u0627\u0644\u062A\u0642\u064A\u0624\u060C \u0627\u0644\u062F\u0648\u062E\u0629\u060C \u0627\u0644\u0646\u0639\u0627\u0633\u060C \u0627\u0644\u0635\u062F\u0627\u0639\u060C \u0627\u0644\u0631\u0624\u064A\u0629 \u0627\u0644\u0645\u0632\u062F\u0648\u062C\u0629 \u0648\u0635\u0639\u0648\u0628\u0627\u062A \u0645\u0639 \u0627\u0644\u0645\u0634\u064A. \u0642\u062F \u062A\u062D\u062F\u062B \u0635\u062F\u0645\u0629 \u0627\u0644\u062D\u0633\u0627\u0633\u064A\u0629 \u0645\u0646 \u0627\u0644\u0639\u0642\u0627\u0631\u060C \u0639\u0644\u0649 \u0627\u0644\u0631\u063A\u0645 \u0645\u0646 \u0623\u0646\u0647\u0627 \u063A\u064A\u0631 \u0634\u0627\u0626\u0639\u0629 \u0627\u0644\u062D\u062F\u0648\u062B. \u0646\u062A\u064A\u062C\u0629 \u0644\u0644\u062A\u0634\u0627\u0628\u0647 \u0627\u0644\u0647\u064A\u0643\u0644\u064A \u0628\u064A\u0646 \u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646 \u0648\u0627\u0644\u0643\u0627\u0631\u0628\u0627\u0645\u0627\u0632\u064A\u0628\u064A\u0646 \u0647\u0646\u0627\u0643 \u0641\u0631\u0635\u0629 \u062D\u0648\u0627\u0644\u064A 25-30\u066A \u0645\u0646 \u0627\u0644\u062A\u0641\u0627\u0639\u0644 \u0628\u064A\u0646 \u0627\u0644\u062F\u0648\u0627\u0626\u064A\u0646."@ar ,
		"Okskarbazepina, OXC \u2013 organiczny zwi\u0105zek chemiczny stosowany jako lek przeciwdrgawkowy i normotymiczny, zaliczany jest do prolek\u00F3w. W 1969 roku zosta\u0142 opatentowany przez J.R. Geigy Ltd. W 1999 roku dopuszczony do sprzeda\u017Cy na terenie ca\u0142ej Unii Europejskiej, w USA od 2000 roku. Stosowany doustnie u doros\u0142ych i dzieci od 6 roku \u017Cycia. Dost\u0119pny na recept\u0119 w formie tabletek lub zawiesiny."@pl ,
		"L'oxcarbazepina o oxcarbamazepina \u00E8 un farmaco chimicamente correlato alla carbamazepina dalla quale deriva; differisce clinicamente da questa per il minor impegno metabolico a livello epatico e per la riduzione dei, se pur rari, fenomeni di grave anemia. Pur con minori effetti collaterali della carbamazepina, l'oxcarbazepina mostra la stessa efficacia, lo stesso meccanismo d'azione sul canale Voltaggio dipendente del Na+ ed \u00E8, inoltre, generalmente usata per il trattamento delle stesse condizioni patologiche. Il farmaco \u00E8 stato studiato dalla Novartis Pharmaceuticals Corporation ed \u00E8 in commercio nel mondo, nelle formulazioni in compresse e sospensione orale, con i nomi commerciali: Alox; Apydan; Atoxecar; Aurene; Oxrate; Oxcazen; Tolep; Trileptal. Solamente in Italia, sin dal 1994, \u00E8 in commercio con il nome Tolep ed \u00E8 disponibile solo in compresse."@it ,
		"La oxcarbazepina es un f\u00E1rmaco antiepil\u00E9ptico utilizado primariamente en el tratamiento de la epilepsia. Mitiga convulsiones focales (parciales) con o sin generalizaci\u00F3n a convulsi\u00F3n t\u00F3nico-cl\u00F3nica en monoterapia de oxcarbazepina o como adyuvante de tratamiento. As\u00ED tambi\u00E9n se ha encontrado evidencia que provoca resultados favorables para la estabilizaci\u00F3n del \u00E1nimo en el trastorno bipolar. La oxcarbazepina es un derivado estructural de la carbamazepina, esta diferencia en la qu\u00EDmica ayuda a reducir el impacto sobre las funciones metab\u00F3licas del h\u00EDgado, as\u00ED como reducir ciertos efectos adversos."@es ,
		"L'oxcarbaz\u00E9pine est un anti\u00E9pileptique (anticonvulsivant) ainsi qu'un thymor\u00E9gulateur ; il est principalement utilis\u00E9 dans le traitement de l'\u00E9pilepsie partielle avec ou sans g\u00E9n\u00E9ralisation secondaire. L'oxcarbaz\u00E9pine est commercialis\u00E9e sous le nom Trileptal par Novartis et disponible dans certains pays sous forme g\u00E9n\u00E9rique."@fr ;
	dbo:wikiPageWikiLink	dbr:Epilepsy ,
		dbr:Methylphenobarbital ,
		dbr:Hyponatremia ,
		dbr:Cytochrome_P450 ,
		dbr:Liver ,
		dbr:CYP3A4 ,
		dbr:Phenobarbital ,
		dbr:Spain ,
		dbr:CYP3A5 ,
		dbr:Hexobarbital ,
		dbr:Kidney ,
		dbr:Sodium_channel ,
		dbr:Dibenzazepine ,
		dbr:Arrhythmia ,
		dbr:Oral_contraceptive_pill ,
		dbr:Diplopia ,
		dbr:Patent ,
		dbc:Dibenzazepines ,
		dbc:Teratogens ,
		dbr:Focal_seizures ,
		dbr:Human_leukocyte_antigen ,
		dbr:Sunburn ,
		dbc:Wikipedia_medicine_articles_ready_to_translate ,
		dbr:Geigy ,
		<http://dbpedia.org/resource/File:Trileptal_tablets.jpg> ,
		dbr:Drug_metabolism ,
		<http://dbpedia.org/resource/Carbon\u2013carbon_double_bond> ,
		<http://dbpedia.org/resource/File:Trileptal_Oral_Suspension_100mg_per_ml.JPG> ,
		dbr:Ketone ,
		dbr:Carbamazepine ,
		dbr:Partial_seizure ,
		dbr:Half-life ,
		dbr:Pregnancy ,
		dbr:Denmark ,
		dbr:Glucuronic_acid ,
		dbr:Nordazepam ,
		dbc:Embryotoxicants ,
		dbc:Prodrugs ,
		dbc:Ketones ,
		dbr:Ataxia ,
		dbr:Prodrug ,
		dbc:Ureas ,
		dbr:Breastfeeding ,
		dbr:Pancreatitis ,
		dbr:Phenytoin ,
		dbr:Novartis ,
		dbc:Mood_stabilizers ,
		dbr:Anaphylaxis ,
		dbr:Oral_administration ,
		dbr:Trigeminal_neuralgia ,
		dbr:Teratology ,
		dbr:Agranulocytosis ,
		dbr:CYP2C19 ,
		dbr:Primidone ,
		dbr:Generic_medication ,
		dbr:Mephenytoin ,
		dbr:Generalized_seizures ,
		dbr:Anemia ,
		<http://dbpedia.org/resource/Stevens\u2013Johnson_syndrome> ,
		dbr:Licarbazepine ,
		dbr:Management_of_drug-resistant_epilepsy ,
		dbc:Anticonvulsants ,
		dbr:Toxic_epidermal_necrolysis ,
		dbr:Bioavailability ,
		dbr:Bipolar_disorder ,
		dbr:Suicide_ideation ,
		dbr:Calcium_channel_blocker ,
		dbr:Portugal ,
		dbc:Novartis_brands ,
		dbr:Diazepam ,
		dbr:Thyroxine ;
	dbp:wikiPageUsesTemplate	<http://dbpedia.org/resource/Template:Drugs.com> .
@prefix dbt:	<http://dbpedia.org/resource/Template:> .
dbr:Oxcarbazepine	dbp:wikiPageUsesTemplate	dbt:Reflist ,
		dbt:Portal_bar ,
		dbt:Ebicite ,
		dbt:Cascite ,
		dbt:Chemspidercite ,
		dbt:Citation_needed ,
		dbt:Short_description ,
		dbt:IPAc-en ,
		dbt:Keggcite ,
		dbt:Stdinchicite ,
		dbt:Fdacite ,
		dbt:Drugbox ,
		dbt:Patent ,
		dbt:Use_dmy_dates ,
		dbt:Ion_channel_modulators ,
		dbt:Neuropathic_pain_and_fibromyalgia_pharmacotherapies ,
		dbt:Mood_stabilizers ,
		dbt:Cite_web ,
		dbt:Tricyclics ,
		dbt:Nbsp ,
		dbt:Anticonvulsants ,
		dbt:Drugbankcite ;
	dbo:thumbnail	<http://commons.wikimedia.org/wiki/Special:FilePath/Oxcarbazepine.svg?width=300> ;
	dbo:wikiPageRevisionID	1119177302 .
@prefix ns18:	<https://druginfo.nlm.nih.gov/drugportal/name/> .
dbr:Oxcarbazepine	dbo:wikiPageExternalLink	ns18:oxcarbazepine .
@prefix xsd:	<http://www.w3.org/2001/XMLSchema#> .
dbr:Oxcarbazepine	dbo:wikiPageLength	"21900"^^xsd:nonNegativeInteger ;
	dbo:wikiPageID	414058 ;
	owl:sameAs	<http://ru.dbpedia.org/resource/\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0438\u043D> .
@prefix dbpedia-pl:	<http://pl.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-pl:Okskarbazepina ,
		<http://www4.wiwiss.fu-berlin.de/sider/resource/drugs/34312> .
@prefix dbpedia-sh:	<http://sh.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-sh:Okskarbazepin ,
		<http://or.dbpedia.org/resource/\u0B05\u0B15\u0B4D\u0B38\u0B15\u0B3E\u0B30\u0B4D\u0B2C\u0B3E\u0B1C\u0B47\u0B2A\u0B3F\u0B28> ,
		<http://fa.dbpedia.org/resource/\u0627\u06A9\u0633\u200C\u06A9\u0627\u0631\u0628\u0627\u0632\u067E\u06CC\u0646> .
@prefix dbpedia-sv:	<http://sv.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-sv:Oxkarbazepin .
@prefix dbpedia-nl:	<http://nl.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-nl:Oxcarbazepine ,
		<http://ja.dbpedia.org/resource/\u30AA\u30AF\u30B9\u30AB\u30EB\u30D0\u30BC\u30D4\u30F3> .
@prefix dbpedia-fi:	<http://fi.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-fi:Okskarbatsepiini .
@prefix dbpedia-it:	<http://it.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-it:Oxcarbazepina ,
		<http://ar.dbpedia.org/resource/\u0623\u0648\u0643\u0633\u0643\u0627\u0631\u0628\u0627\u0632\u064A\u0628\u064A\u0646> .
@prefix dbpedia-pt:	<http://pt.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-pt:Oxcarbazepina .
@prefix dbpedia-cy:	<http://cy.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-cy:Ocscarbasepin .
@prefix dbpedia-sr:	<http://sr.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-sr:Okskarbazepin .
@prefix ns29:	<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/> .
dbr:Oxcarbazepine	owl:sameAs	ns29:DB00776 .
@prefix ns30:	<https://global.dbpedia.org/id/> .
dbr:Oxcarbazepine	owl:sameAs	ns30:iRwf ,
		<http://fr.dbpedia.org/resource/Oxcarbaz\u00E9pine> .
@prefix dbpedia-de:	<http://de.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-de:Oxcarbazepin .
@prefix dbpedia-hu:	<http://hu.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-hu:Oxkarbazepin ,
		<http://azb.dbpedia.org/resource/\u0627\u0648\u06A9\u0633\u0643\u0631\u0628\u0627\u0632\u067E\u064A\u0646> ,
		wikidata:Q176301 .
@prefix dbpedia-es:	<http://es.dbpedia.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	dbpedia-es:Oxcarbazepina ,
		<http://uk.dbpedia.org/resource/\u041E\u043A\u0441\u043A\u0430\u0440\u0431\u0430\u0437\u0435\u043F\u0456\u043D> ,
		<http://ro.dbpedia.org/resource/Oxcarbazepin\u0103> ,
		<http://he.dbpedia.org/resource/\u05D0\u05D5\u05E7\u05E1\u05E7\u05D0\u05E8\u05D1\u05D0\u05D6\u05E4\u05D9\u05DF> .
@prefix yago-res:	<http://yago-knowledge.org/resource/> .
dbr:Oxcarbazepine	owl:sameAs	yago-res:Oxcarbazepine ,
		dbr:Oxcarbazepine ,
		<http://rdf.freebase.com/ns/m.025gxv> .
@prefix gold:	<http://purl.org/linguistics/gold/> .
dbr:Oxcarbazepine	gold:hypernym	dbr:Drug .
@prefix prov:	<http://www.w3.org/ns/prov#> .
dbr:Oxcarbazepine	prov:wasDerivedFrom	<http://en.wikipedia.org/wiki/Oxcarbazepine?oldid=1119177302&ns=0> ;
	foaf:isPrimaryTopicOf	wikipedia-en:Oxcarbazepine ;
	dbp:chembl	1068 ;
	dbo:chEMBL	"1068" ;
	dbp:atcSuffix	"AF02"@en ;
	dbo:alternativeName	"Trileptal, Oxtellar XR, others"@en ;
	dbp:n	2 ;
	dbp:chemspiderid	31608 ;
	dbp:c	15 ;
	dbp:verifiedrevid	445068911 ;
	dbp:h	12 ;
	dbo:pubchem	"34312" ;
	dbp:routesOfAdministration	dbr:Oral_administration ;
	dbp:o	2 ;
	dbp:pubchem	34312 ;
	dbp:stdinchikey	"CTRLABGOLIVAIY-UHFFFAOYSA-N"@en ;
	dbp:smiles	"O=C3c1cNCN"@en ;
	dbp:watchedfields	"changed"@en ;
	dbo:fdaUniiCode	"VZI5B1W380" ;
	dbp:legalUk	"POM"@en ;
	dbp:iupacName	1011 ;
	dbp:unii	"VZI5B1W380"@en ;
	dbp:casNumber	28721 ;
	dbp:atcPrefix	"N03"@en ;
	dbp:stdinchi	1 ;
	dbo:casNumber	"28721-07-5" ;
	dbp:medlineplus	"a601245"@en ;
	dbo:medlinePlus	"a601245" ;
	dbp:legalEu	"Rx-only"@en ;
	dbp:dailymedid	"Oxcarbazepine"@en ;
	dbp:iupharLigand	7254 ;
	dbp:pregnancyAu	"D"@en ;
	dbp:legalAu	"S4"@en ;
	dbp:width	175 ;
	dbp:legalUs	"Rx-only"@en .
@prefix dbd:	<http://dbpedia.org/datatype/> .
dbr:Oxcarbazepine	dbp:image	"259200.0"^^dbd:second ;
	dbo:kegg	"D00533" ;
	dbp:excretion	dbr:Kidney ;
	dbp:eliminationHalfLife	"-18000.0"^^dbd:second ;
	dbo:drugbank	"DB00776" ;
	dbp:drugbank	"DB00776"@en ;
	dbp:tradename	"Trileptal, Oxtellar XR, others"@en ;
	dbp:bioavailability	">95%"@en ;
	dbp:metabolism	dbr:Liver ;
	dbp:kegg	"D00533"@en .
dbr:Jeavons_syndrome	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Severe_cutaneous_adverse_reactions	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Sleep-related_hypermotor_epilepsy	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:List_of_cytochrome_P450_modulators	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Perampanel	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Macropsia	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
<http://dbpedia.org/resource/Unverricht\u2013Lundborg_disease>	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:ATC_code_N03	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:Oxitriptyline	dbo:wikiPageWikiLink	dbr:Oxcarbazepine .
dbr:ATC_code_N03AF02	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .
dbr:ATCvet_code_QN03AF02	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .
dbr:Apydan	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .
dbr:Oxtellar_XR	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .
dbr:Oxicodal	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .
dbr:Trileptil	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .
dbr:Trileptol	dbo:wikiPageWikiLink	dbr:Oxcarbazepine ;
	dbo:wikiPageRedirects	dbr:Oxcarbazepine .  <script>parent.window.postMessage('ixistenz.url:http://dbpedia.org/data/Oxcarbazepine.n3', '*'); </script> <div id='browserdiffcontainer' style='position: fixed; right: 10px; top: 10vh; min-width: 60px;  border: 1px solid white; background: rgb(251, 189, 0);; opacity: 0.9; font-family: helvetica, arial, sans serif;  font-size: 12px; z-index: 20001; padding-bottom: 20px;'><div onclick="toggle('browserdiffcontainerlist'); return false;" style='background: rgb(151, 89, 0);; color: white; '><strong>&nbsp; <span class='glyphicon glyphicon-minus'></span> NODES</strong></div><div id='browserdiffcontainerlist' style='padding-left: 10px; padding-right: 5px; max-height: 50vh; overflow: auto; '><div><a href='#diffid127' style='color: white;' onClick="parent.window.postMessage('ixistenz.opendiff:127', '*');; return false;" style='text-decoration: none; '>admin </a> <a style='color: white;' href='#diffid127'><sup>4</sup></a></div><div><a href='#diffid884' style='color: white;' onClick="parent.window.postMessage('ixistenz.opendiff:884', '*');; return false;" style='text-decoration: none; '>Idea </a> <a style='color: white;' href='#diffid884'><sup>3</sup></a></div><div><a href='#diffid119' style='color: white;' onClick="parent.window.postMessage('ixistenz.opendiff:119', '*');; return false;" style='text-decoration: none; '>idea </a> <a style='color: white;' href='#diffid119'><sup>3</sup></a></div><div><a href='#diffid123' style='color: white;' onClick="parent.window.postMessage('ixistenz.opendiff:123', '*');; return false;" style='text-decoration: none; '>INTERN </a> <a style='color: white;' href='#diffid123'><sup>1</sup></a></div><div><a href='#diffid878' style='color: white;' onClick="parent.window.postMessage('ixistenz.opendiff:878', '*');; return false;" style='text-decoration: none; '>Note </a> <a style='color: white;' href='#diffid878'><sup>2</sup></a></div></div></div>
<script>
function toggle( divname ) {
  var x = document.getElementById( divname );
  if (x.style.display === 'none') {
    x.style.display = 'block';
  } else {
    x.style.display = 'none';
  }
} </script>